NextPlat (NASDAQ:NXPL – Get Free Report) is projected to announce its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect NextPlat to post earnings of ($0.21) per share and revenue of $11.00 million for the quarter. Individuals can check the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 13, 2026 at 8:30 AM ET.
NextPlat (NASDAQ:NXPL – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.The firm had revenue of $9.86 million during the quarter. On average, analysts expect NextPlat to post $-1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
NextPlat Trading Down 0.2%
Shares of NXPL stock opened at $6.09 on Wednesday. The company has a market capitalization of $16.50 million, a PE ratio of -1.41 and a beta of 1.83. NextPlat has a 52-week low of $3.38 and a 52-week high of $11.10. The business’s fifty day moving average is $6.46 and its 200 day moving average is $5.98. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.12 and a current ratio of 2.56.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on NXPL
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new stake in shares of NextPlat Corp. (NASDAQ:NXPL – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat at the end of the most recent reporting period. 1.30% of the stock is owned by hedge funds and other institutional investors.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Read More
- Five stocks we like better than NextPlat
- Caterpillar’s Record Quarter May Have Reset the Stock’s Ceiling
- The Real Reason Amazon Hit a $3 Trillion Valuation
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
